Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN KANE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1164556429
CMS profile
188499
Location
GLEN OAKS, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$170,526.37

101 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
H. Lundbeck A S $59,745.22 21
Otsuka Pharmaceutical Co., Ltd. $33,924.02 21
Teva Pharmaceuticals USA, Inc. $27,868.93 18
Sumitomo Pharma Co., Ltd. $18,869.85 14
Alkermes, Inc. $16,865.61 11
Boehringer Ingelheim Pharmaceuticals, Inc. $4,753.91 8
Otsuka America Pharmaceutical, Inc. $3,784.91 4
Merck Sharp & Dohme LLC $3,255.00 1
Biogen, Inc. $1,430.40 2
Lundbeck LLC $28.52 1

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN KANE

NPI 1164556429 · CMS profile ID 188499

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

GLEN OAKS, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164556429?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN KANE, NPI 1164556429, CMS profile ID 188499. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164556429?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JOHN KANE, NPI 1164556429, CMS profile ID 188499. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164556429?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JOHN KANE, NPI 1164556429, CMS profile ID 188499, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1164556429?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

101 matching records · $170,526.37 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 101 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 101.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
H. Lundbeck A S $20,000.0007/16/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059231681 CMS
H. Lundbeck A S $13,610.0007/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059231687 CMS
H. Lundbeck A S $718.0007/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059231693 CMS
H. Lundbeck A S $1,580.0007/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059231697 CMS
Teva Pharmaceuticals USA, Inc. $4,549.5607/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670091 CMS
Teva Pharmaceuticals USA, Inc. $3,775.0006/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670175 CMS
Alkermes, Inc. $500.0006/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847293 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $82.8805/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996802191 CMS
Alkermes, Inc. $41.9305/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847291 CMS
Lundbeck LLC $28.5205/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032255939 CMS
Teva Pharmaceuticals USA, Inc. $110.8005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670143 CMS
Teva Pharmaceuticals USA, Inc. $1,510.0005/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061992427 CMS
Teva Pharmaceuticals USA, Inc. $30.3605/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670159 CMS
Teva Pharmaceuticals USA, Inc. $29.0205/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670163 CMS
Teva Pharmaceuticals USA, Inc. $68.9305/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670167 CMS
Teva Pharmaceuticals USA, Inc. $29.0205/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670185 CMS
Teva Pharmaceuticals USA, Inc. $395.1605/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670155 CMS
Teva Pharmaceuticals USA, Inc. $190.0005/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670161 CMS
Teva Pharmaceuticals USA, Inc. $169.5805/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670169 CMS
Teva Pharmaceuticals USA, Inc. $249.0005/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670173 CMS
Alkermes, Inc. $147.3604/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847287 CMS
Alkermes, Inc. $7,560.0004/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847289 CMS
Alkermes, Inc. $7,500.0003/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847285 CMS
Teva Pharmaceuticals USA, Inc. $2,160.0003/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670181 CMS
Teva Pharmaceuticals USA, Inc. $2,520.0003/09/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061992431 CMS
Alkermes, Inc. $143.6003/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847275 CMS
Alkermes, Inc. $143.6003/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847277 CMS
Alkermes, Inc. $183.7903/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847279 CMS
Alkermes, Inc. $253.2503/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847281 CMS
Alkermes, Inc. $315.0003/07/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847283 CMS
Sumitomo Pharma Co., Ltd. $20.5002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042761021 CMS
Sumitomo Pharma Co., Ltd. $18.1802/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042761027 CMS
Sumitomo Pharma Co., Ltd. $44.6902/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042761033 CMS
Sumitomo Pharma Co., Ltd. $10.6302/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042761039 CMS
Sumitomo Pharma Co., Ltd. $176.3002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042761045 CMS
Alkermes, Inc. $77.0802/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022847273 CMS
Biogen, Inc. $1,401.7902/09/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012251923 CMS
Otsuka America Pharmaceutical, Inc. $135.0002/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014451795 CMS
Otsuka America Pharmaceutical, Inc. $15.3602/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014451805 CMS
Otsuka America Pharmaceutical, Inc. $16.5502/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014451815 CMS
Sumitomo Pharma Co., Ltd. $2,200.0001/31/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429851 CMS
Sumitomo Pharma Co., Ltd. $3,600.0001/31/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429859 CMS
Biogen, Inc. $28.6101/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012232673 CMS
Sumitomo Pharma Co., Ltd. $154.0001/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429875 CMS
Sumitomo Pharma Co., Ltd. $21.8301/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429882 CMS
Sumitomo Pharma Co., Ltd. $809.3101/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429893 CMS
Sumitomo Pharma Co., Ltd. $416.7901/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429901 CMS
Sumitomo Pharma Co., Ltd. $186.7601/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429909 CMS
Sumitomo Pharma Co., Ltd. $3.0801/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 994429915 CMS
Teva Pharmaceuticals USA, Inc. $2,160.0001/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056670177 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $73,719.84 52
PY2020 $88,292.48 51
PY2021 $116,535.99 39
PY2022 $140,317.84 79
PY2023 $170,526.37 101
PY2024 $191,157.37 127
PY2025 $36,353.29 25

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,736,533.65 2
PY2021 Recipient $4,998.40 1
PY2019 Recipient $7,238.44 5
PY2019 Principal investigator $1,413,088.34 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,181,533.65 07/15/2025 Non-covered Recipient Entity
Northwell Health
An Open-Label Study to evaluate the efficacy and tolerability of Xanomeline/Trospium in First Episode/Early Phase Schizophrenia Patients No dispute reported 06/30/2026 1235995253
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $555,000.00 04/28/2025 Non-covered Recipient Entity
Northwell Health
An Open-Label Study to evaluate the efficacy and tolerability of Xanomeline/Trospium in First Episode/Early Phase Schizophrenia Patients No dispute reported 06/30/2026 1235995255